World Hepatitis Summit 2022 urges action to eliminate viral hepatitis as unexplained hepatitis cases in children rise globally

Seventy-fifth World Health Assembly noted the 2022-2030 Global Health Sector Strategy on HIV, hepatitis and STIs

SAGE April 2022 meeting highlights

Zero Discrimination Day, 1 March 2022

Public notice and comment on new members of the Global Validation Advisory Committee (GVAC)

WHO publishes updated guidance on validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus

SAGE October 2021 meeting highlights

WHO announces the update of HCV guidelines on testing and treatment

Public notice and comment on new Global Validation Advisory Committee (GVAC) members

“Hepatitis can’t wait” - WHO commemorates World Hepatitis Day 2021

WHO releases first guidelines on hepatitis C virus self-testing

WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination

WHO announces the update of the “Consolidated Guidelines on HIV, Hepatitis and STI prevention, diagnosis, treatment and care for key populations”

Public notice and comment on new Global Validation Advisory Committee (GVAC) members

Developing global health sector strategies on HIV, viral hepatitis and sexually transmitted infections for 2022-2030

New report highlights global progress on reducing HIV, viral hepatitis and sexually transmitted infections and signals need for renewed efforts to reach 2030 targets

WHO and partners urge countries to fast-track implementation and scale-up of HIV self-testing and other innovative HIV testing approaches in Asia and the Pacific

WHO highlights progress in accelerating access to hepatitis C diagnostics and treatment in low- and middle-income countries

WHO announces development of new guidance on Hepatitis C self-testing

WHO-commissioned global systematic review finds high HCV prevalence and incidence among men who have sex with men